SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-22-016525
Filing Date
2022-04-28
Accepted
2022-04-28 16:11:46
Documents
4
Period of Report
2022-06-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A edge20001347x1_def14a.htm DEF 14A 813852
2 edge20001347x1_pc01.jpg GRAPHIC 546027
3 edge20001347x1_pc02.jpg GRAPHIC 437685
4 sig_heatherturner.jpg GRAPHIC 14765
  Complete submission text file 0001140361-22-016525.txt   2188954
Mailing Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Filer) CIK: 0001806952 (see all company filings)

IRS No.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40502 | Film No.: 22866657
SIC: 2834 Pharmaceutical Preparations